Cargando…

Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers

PURPOSE: This study aimed to estimate utility values for health states relating to oral immunotherapy (OIT) for peanut allergy (PA), for children with PA and their caregivers. PATIENTS AND METHODS: Two methods were used: an online survey and structured interviews. Both methods assessed current utili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallop, Katy, Acaster, Sarah, de Vries, Jane, Browne, Richard, Ryan, Robert, Baker, Sarah, Du Toit, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129262/ https://www.ncbi.nlm.nih.gov/pubmed/35619589 http://dx.doi.org/10.2147/PPA.S357864

Ejemplares similares

Allergy to Peanuts imPacting Emotions And Life (APPEAL): the impact of peanut allergy on children, adolescents, adults and caregivers in France
por: Couratier, Pascale, et al.
Publicado: (2020)

Psychosocial and productivity impact of caring for a child with peanut allergy
por: Acaster, Sarah, et al.
Publicado: (2020)

Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland
por: Tsoumani, Marina, et al.
Publicado: (2022)

The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers
por: Nowak-Wegrzyn, Anna, et al.
Publicado: (2021)

APPEAL‐2: A pan‐European qualitative study to explore the burden of peanut‐allergic children, teenagers and their caregivers
por: DunnGalvin, Audrey, et al.
Publicado: (2020)

The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity
por: McCann, William, et al.
Publicado: (2021)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosis
por: Acaster, Sarah, et al.
Publicado: (2023)

Peanut allergy burden survey: Factors associated with health‐related quality of life in adolescents
por: McCann, William A., et al.
Publicado: (2023)

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy
por: Bird, J. Andrew, et al.
Publicado: (2023)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020)

Oral immunotherapy for peanut allergy: The con argument
por: Fiocchi, Alessandro, et al.
Publicado: (2020)

Peanut allergy: Beyond the oral immunotherapy plateau
por: Bruton, Kelly, et al.
Publicado: (2021)

Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice
por: Portnoy, Jay, et al.
Publicado: (2022)

Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States
por: Blaiss, Michael S, et al.
Publicado: (2021)

White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects
por: Lange, Lars, et al.
Publicado: (2021)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

Mouse strain differences in response to oral immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Defining the window of opportunity and target populations to prevent peanut allergy
por: Roberts, Graham, et al.
Publicado: (2023)

Peanut Allergy: An Overview
por: Al-Ahmed, Nasser, et al.
Publicado: (2008)

The global burden of illness of peanut allergy: A comprehensive literature review
por: Lieberman, Jay A., et al.
Publicado: (2021)

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
por: Lavine, Elana, et al.
Publicado: (2014)

Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses
por: Logan, Kirsty, et al.
Publicado: (2022)

Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2019)

Bronchial hyperresponsiveness and asthma during oral immunotherapy for egg or peanut allergy in children
por: Burman, Janne, et al.
Publicado: (2022)

Accurate and reproducible diagnosis of peanut allergy using epitope mapping
por: Suárez‐Fariñas, Mayte, et al.
Publicado: (2021)

Developing Therapies for Peanut Allergy
por: Bublin, Merima, et al.
Publicado: (2014)

2078- Immunotherapy – 2078. Allergen-specific oral immunotherapy for peanut allergy: a Cochrane systematic review
por: Nurmatov, Ulugbek, et al.
Publicado: (2013)

A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis
por: Acaster, Sarah, et al.
Publicado: (2013)

Open‐label follow‐on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy
por: Fernandez‐Rivas, Montserrat, et al.
Publicado: (2021)

Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014)

HLA alleles and sustained peanut consumption promote IgG4 responses in subjects protected from peanut allergy
por: Kanchan, Kanika, et al.
Publicado: (2022)

Efficacy and safety of oral immunotherapy for peanut allergy: a pilot study in Singaporean children
por: Zhong, Youjia, et al.
Publicado: (2018)

Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology
por: Lange, Lars, et al.
Publicado: (2014)

Long Non-Coding RNAs Expressed in the Peanut Allergy for Understanding the Pathophysiology of Peanut Allergy Rat Model
por: Liu, Manman, et al.
Publicado: (2022)

Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children
por: Santos, Alexandra F., et al.
Publicado: (2014)

Children and caregiver proxy quality of life from peanut oral immunotherapy trials
por: Galvin, Audrey Dunn, et al.
Publicado: (2022)

Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013)

Adhesion molecules in experimental peanut allergy
por: Bennett, Jami, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_iv40luc28e063vf8pc84d8tbaq